Can't wait to hear the latest excuse for not launching in Canada at the corp. conf. call. You can only deny as a result of "ignorance" for so long. If the CEO is smart, he'll move on by end of the year to avoid lawsuits.
If he hates this company and likes the other stocks so much? Because he wants you to sell your stock cheap and invest in his other stocks so he can sell on the increase and make money! AE37 will have huge cost benefits over other cancer drugs, it's already gone through the largest phase 2 trial for breast cancer vaccine ever, and they will soon report excellent results. A partner or buyout is coming. You better dump your other stocks and buy more now Omega before you miss the train.
That launch is "just around the corner"? Hopefully, no one will ask them why Abbott hasn't launched in three years since Canadian government approval!! My guess is they will give the ole " European partners are preparing to launch as we speak" bull with no specifics as usual. Look for another stock dillution after the conference.
What's oral insulin have to do with AE37? NOTHING! Generex put Oral Insulin on the back burner probably two years ago. The potential is with Antigen Express and AE37. That's why Fletcher wanted to spin off Antigen Express so he could lower the number of shares outstanding and keep issuing more shares to fund development (which I don't particularly agree with because Management makes out and the current Generex shareholders get screwed). Fletcher needs to earn his pay and either get a partner or buyout. But the point is that AE37 is the focus right now...not Oral Insulin.
LOL..."saving" investors...that's a good one. More like disgrunted because you lost money in the past on this....oh well, that happens. I'll admit that Anna Gluskin (former CEO) put all the resources into the diabetes side of the house. By the time she realized that way too much money was being spent on developing it and that Antigen Express had better opportunity, it was too late. She had already dilluted the heck out of the stock. That doesn't mean that big gains still can't occur if AE37 pans out. I don't think the US Army would be helping to sponser the drug trials if they didn't think there was some potential. And the FDA would not have suggested Phase 3 trials on a fast track. Morever, there seems to be minimal risk with the safety according to the comments on the Phase 2 results.
Even when the market as a whole is tanking. Must really frustrate the bashers. They're trying so hard to keep the price down and buy up as much as they can....too bad, so sad.
LOL...Canada approved over 3 years ago and still not launched by Abbott. First European approvals were about 8 months ago and still no launch. The first quarter of this year is almost over and still no launch. Sorry folks....this is looking like a scam....pure and simple. When Apricus announces another launch delay again into second half of the year this stock is going to tank big time.
No one is going to get excited about phase 1 results at the last conference. But with good phase 2 results on a 300 patient study, now there's something to get excited about. BTW...there have been a number of cancer / immunotherapy company buyouts by larger companies since then.
Ya...we should trust you instead...LOL...hopefully, come June you will go away and find some other stock message board to be obnoxious on
PRESS RELEASE FROM 2/27/14
Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients
"The identification of viable biomarkers is of particular interest in the field of cancer immunotherapy as generation of an immune response and subsequent efficacy can be delayed significantly beyond what is observed for conventional cancer therapies. "These studies complement nicely the data from our Phase II trial of AE37 in breast cancer patients," commented Dr. Eric von Hofe, Ph.D., President of Antigen Express. "They represent an important first step toward a comprehensive search for biomarkers to aid in the development of AE37 and will likely have application to the field of cancer immunotherapy in general."
READ BETWEEN THE LINES....IT's working!
My guess is by the "third" quarter or maybe by "the end of the year". I wonder what excuse they'll use this time for the lack of Canadian launch after three years or maybe they'll just avoid the subject all together. Or maybe they'll finally admit that Abbott is not interested in launching Vitaros in it's current form which means more trials, more submissions, more delays for a couple more years.
Then why don't you and all your aliases just sell your stock to the rest of us and get off this board for good? Why do you waste your time here unless you're a paid basher trying to keep the stock price lower?
Anyone with a yahoo name of gwana "6969" would not have a single client unless they were idiots.
That anyone would still invest in this company. It's been THREE years people since Canadian Govt. approval and they still haven't launch anything! How blind can you be??! NO COMPANY ON EARTH would wait that long to launch their most important product! Abbott knows that this is a scam!
Wouldn't you want to be pumping this stock instead of bashing in order to get the price up for your client when he sold? You just showed how you are a desperate loser liar.
To keep the price of this stock down and under the radar. The truth is that immunotherapy companies are the hot ticket right now and are being swallowed up right and left by big Pharma companies. The market cap of this company is no where near that of other similar companies. Translation: if the results of the Phase 2 study are as good as they would lead to believe, I can see this company being bought out for $300-$500 million easy which would return a 10-15X return to stockholders. Generex offers a LOW cost solution that other companies can't match and would potentially bring billions to a large drug company. The bashers really want your shares!